Latest filing published 29 Nov 2022 for Innate Pharma. Read the official filing
No signal scores available.
Mondher Mahjoubi discloses dealings in Innate Pharma to AMF. Over a trading history stretching from 25 July 2022 to 4 November 2022, the count stands at 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 29 November 2022 with a share grant in Innate Pharma. These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations